International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AMLSwati Naik, Saar Gill, Naomi Taylor et al.|Blood Advances|2025Cited by 7
Ten-year experience of CD22 CAR T cells for children and young adults with B-cell acute lymphoblastic leukemiaAlexandra Dreyzin, Nirali N. Shah, Toni Foley et al.|Blood Advances|2025Cited by 5
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategiesAlexandra Dreyzin, Nirali N. Shah, Anne Marijn Kramer et al.|Cytotherapy|2025Cited by 1
CD22 CAR T-Cells Manufactured in Prodigy System and in Bag Culture Yield Equivalent Responses for B-ALLAlexandra Dreyzin, Nirali N. Shah, Anne Marijn Kramer et al.|Transplantation and Cellular Therapy|2024Cited by 0
Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic LeukemiaBrynn B. Duncan, Nirali N. Shah, Alexander W. Rankin et al.|Transplantation and Cellular Therapy|2025Cited by 0